Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $833000.0.

  • Biofrontera's Other Non-Current Liabilities fell 4797.0% to $833000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $833000.0, marking a year-over-year decrease of 4797.0%. This contributed to the annual value of $1.2 million for FY2024, which is 7030.88% down from last year.
  • As of Q3 2025, Biofrontera's Other Non-Current Liabilities stood at $833000.0, which was down 4797.0% from $548000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Other Non-Current Liabilities ranged from a high of $12.9 million in Q4 2021 and a low of $548000.0 during Q2 2025
  • Its 5-year average for Other Non-Current Liabilities is $5.3 million, with a median of $4.9 million in 2021.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 2063225.81% in 2021, then tumbled by 9401.59% in 2025.
  • Over the past 5 years, Biofrontera's Other Non-Current Liabilities (Quarter) stood at $12.9 million in 2021, then plummeted by 77.88% to $2.8 million in 2022, then surged by 48.08% to $4.2 million in 2023, then crashed by 70.31% to $1.2 million in 2024, then tumbled by 33.36% to $833000.0 in 2025.
  • Its Other Non-Current Liabilities was $833000.0 in Q3 2025, compared to $548000.0 in Q2 2025 and $702000.0 in Q1 2025.